onsdag 28 januari 2009

Svensken som utmanar den globala läkemedelsindustrin

Att läkemedels industrin tillsammans med livsmedels industrin lever i en mycket tät symbios med de myndigheter och forskare som ger rekommendationer om vår mat och vår hälsa och att de med detta i realiteten styr agendan blir mer och mer uppenbart för allt fler.

Vill man sätta sig in i de arbetsmetoder och på det sätt de stora läkemedels bolagen arbetar ex rekommenderar jag verkligen er att läsa Peter Rost bok "Sjuka pengar". Rost var tidigare vice vd för Pfizer och har altså en unik insyn i branchen.

Whistleblower: Dr. Peter Rost before Congress
http://se.youtube.com/watch?v=OBSZpQWv5Wc

Peter Rost "The Whistleblower" author interviewed
http://se.youtube.com/watch?v=05hoNczX1h8

Cheerleader Drug Reps
http://se.youtube.com/watch?v=oNQJIyOZqtA&feature=PlayList&p=0C2D5E926FC6AB85&playnext=1&index=2

Sjuka pengar
http://butik.pagina.se/fb_produkt.asp?art=72411309

Peters egna Blogg
http://www.peterrost.blogspot.com/

In the world of medicine, "key opinion leader" is the somewhat Orwellian term used to describe the senior doctors who help drug companies sell drugs.These influential doctors are engaged by industry to advise on marketing and help boost sales of new medicines. Across all specialties, in hospitals and universities everywhere, many leading specialists are being paid generous fees to peddle influence on behalf of the world’s biggest drug companies.

Kimberly Elliott, who was a drug company sales representative for almost two decades in the United States, puts it directly. "Key opinion leaders were salespeople for us, and we would routinely measure the return on our investment, by tracking prescriptions before and after their presentations," she said. "If that speaker didn’t make the impact the company was looking for, then you wouldn’t invite them back."
http://www.bmj.com/cgi/content/short/336/7658/1402

Inga kommentarer: